Related Experiment Video

Updated: Aug 11, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Tuberous sclerosis complex: molecular pathogenesis and animal models

Leandro R Piedimonte1, Ian K Wailes, Howard L Weiner

  • 1Division of Pediatric Neurosurgery, Department of Neurosurgery, New York University School of Medicine, New York, New York 10016, USA.

Neurosurgical Focus
|February 8, 2006
PubMed

Insights

Mutations in TSC1 and TSC2 genes disrupt tuberin and hamartin signaling, causing tuberous sclerosis complex (TSC) brain lesions and neurological issues. Animal models are key to understanding TSC and developing future treatments.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Developmental Biology

Background:

  • Tuberous sclerosis complex (TSC) arises from mutations in TSC1 or TSC2 genes.
  • These mutations disrupt the hamartin-tuberin protein complex, crucial for cell signaling.
  • TSC leads to abnormal brain development, causing lesions like cortical tubers.

Purpose of the Study:

  • To investigate the cellular and molecular mechanisms underlying TSC.
  • To explore the role of the hamartin-tuberin complex in brain development.
  • To highlight the utility of animal models in TSC research.

Main Methods:

  • Analysis of mutations in TSC1 and TSC2 genes.
  • Study of hamartin and tuberin protein interactions.
  • Utilizing conventional and conditional knockout mouse models.

Main Results:

  • Disruption of TSC1/TSC2 impairs normal cellular differentiation, migration, and proliferation in the brain.
  • This disruption leads to the formation of cortical tubers, characteristic of TSC.
  • TSC impacts the central nervous system, causing epilepsy, intellectual disability, and autism.

Conclusions:

  • The hamartin-tuberin complex is vital for normal brain development.
  • Defects in this complex due to TSC1/TSC2 mutations result in the diverse neurological manifestations of TSC.
  • Animal models offer promising avenues for developing targeted TSC therapies.

More Related Videos

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...